FRAT1 and central nervous system cancer: The apparent correlation of high levels of FRAT1 expression with the more advanced stages of glioma and other cancers is suggestive of its potential as a selective target for therapeutics; however, cell-specific targeting could also potentially be employed to provide additional selectivity.